INJ.LEUCOVORIN CALCIUM 50 MG

INJ.LEUCOVORIN CALCIUM 50 MG
Product Description

- AN ACTIVE METABOLITE OF FOLIC ACID  ( ALSO CALLED  FOLINIC ACID AND CICTROVORUM FACTOR ), WHICH DOSE NOT REQUIRE METABOLISM BY DIHYDROFOLATE REDUCTASE , THE MOLECULAR TARGET OF FOLATE ANTAGONIST- TYPE CHEMOTHERAPEUTIC DRUGS.

Read more Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile

More Products from RMPL Pharma LLP (99)

  • INJ. CARMENDAN 12.5 MG

    Product INJ. CARMENDAN 12.5 MG

    LIVOSIMENDAN 12. MG INJECTION.
  • Inj. Melkeran 50 mg

    Product Inj. Melkeran 50 mg

    Inj. Melphalan 50 mg
  • Tab. Low-K

    Product Tab. Low-K

    POTASSIUM CHLORIDE TABLETS
  • Ves-ATRA Softgel

    Product Ves-ATRA Softgel

    Tretinoin Soft Gelatin Capsules.
  • INJ. MELKERAN 50 MG

    Product INJ. MELKERAN 50 MG

    - PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .
  • TAB. MELKERAN 2 MG

    Product TAB. MELKERAN 2 MG

    - PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .
  • INJ. HOLOFOS 2 MG

    Product INJ. HOLOFOS 2 MG

    - INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.
  • INJ. HOLOFOS 1 GM

    Product INJ. HOLOFOS 1 GM

    - INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.
  • INJ. 5 - FLU 500 MG

    Product INJ. 5 - FLU 500 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
  • INJ. 5 - FLU 250 MG

    Product INJ. 5 - FLU 250 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
  • TAB. ARIMIZOLE 1 MG

    Product TAB. ARIMIZOLE 1 MG

     - ANASTRAZOLE  IS USE FOR ADJUTANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER.- FOR THE FIRST LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER.
    - FOR THE TRE...
  • INJ. ELOPLAT 100 MG

    Product INJ. ELOPLAT 100 MG

    - ADJUVANT TREATMENT OF STAGE III COLON CANCER  IN PATIENTS WHO HAVE UNDERGONE COMPLETE RESECTION OF THE PRIMARY TUMOUR.- TREATMENT OF - ADVANCED COLORECTAL CANCER.
show all 99 other products

RMPL Pharma LLP resources (1)

  • RMPL PHARMA LLP.

    Brochure RMPL PHARMA LLP.

    The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.